美国Iris Diagnostics
Iris集团于1979年成立，总部位于洛杉矶北部，并在纳斯达克上市。Iris集团旗下包括：Iris诊断、Iris德国公司、Iris 分子诊断、Iris样品处理。其中Iris诊断一直致力于开发和研究体外诊断产品，为客户提供可靠的成本效益解决方案。经验丰富的研究人员不断地开发创新体外诊断技术以扩大最初的产品平台，因为不懈的努力，IRIS诊断的数字影像处理技术水平在业界领先，且是尿液分析系统的全球领导者。

数图诊断（中国）有限公司是一家专业从事医疗检验器械，诊断试剂及耗材的外资企业。公司总部坐落于国际金融中心——香港，同时设立了华图医疗器械（上海）有限公司和广州市数图医疗器械有限公司，并准备在华北，西南等中国区域设立其他分公司。数图诊断与美国知名企业——IRIS诊断于2010年在中国市场上筑成战略伙伴的合作关系，协力打造专业品牌，为中国的医疗器械行业带来真正专业的诊断服务。 
 

数图诊断（中国）有限公司
地址：香港铜锣湾希慎道33号利园45楼
电话：+852 2543 4268
传真：+852 3909 2655

华图医疗器械（上海）有限公司
地址：上海市杨浦区黄兴路1725号怡富商务广场701室（200433）
电话：+86 21 6095 6365
传真：+86 21 6095 6373

广州数图医疗器械有限公司
地址：广州市环市东路486号广粮大厦609室（510075）
电话：+86 20 87302629
传真：+86 20 87302629

Iris Diagnostics' in-vitro diagnostic (IVD) imaging systems are based on patented and proprietary automated intelligent microscopy (AIM) technology for automating microscopic procedures performed in clinical laboratories. AIM combines Iris Diagnostics' capabilities in automated specimen presentation, including its patented slideless microscope and proprietary high-speed digital processing hardware and software to classify and present images of microscopic particles in easy-to-view displays.

Iris Diagnostics has created a family of automated microscopy systems. There are more than 450 such systems installed in 11 countries worldwide.

Iris Diagnostics' urinalysis systems provide the most cost-effective and accurate way of performing routine urinalysis today. 

 Iris is a customer-focused organization driven by innovation. By listening to our customers, we better understand your needs, including the value you expect from our products and services. Iris Diagnostics has served the global urinalysis testing market for over 25 years and currently is proud to offer a portfolio of urinalysis instrumentation products under the names of iQ®200SPRINT™, iQ®200ELITE™ and iQ®200SELECT™ Systems, iRICELL® workstations, iChem®VELOCITY™ and iChem®100.

Urinalysis is an effective, non-invasive tool in the screening and diagnosis of disease states such as Urinary Tract Infection, Diabetes, Glomerulonephritis and early stage kidney failure. With early detection leading to both prompt and more accurate treatments, urinalysis has proven to be an invaluable patient management tool.

Iris Diagnostics is focused on products that analyze particles and living cell forms and structures, or morphology, in both urine and a variety of body fluids. Our product portfolio leverages our strengths in flow imaging technology, particle recognition software algorithms and integrated automation to bring productivity, quality, and standardization to the laboratory environment, where labor-intensive processes result in significant cost and workflow challenges for our customers.